On the basis of the protection observed in development of atherosclerosis after MAP4K4 depletion in genetic mouse models (Figs 2 and 3), we attempted to verify these results and determine whether inhibiting the protein kinase activity of MAP4K4 would also protect against atherosclerosis development. The gene discussed is WEE1; the disease is atherosclerosis.